Summit Securities Group’s Adverum Biotechnologies ADVM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2014
Q4
Sell
-48
Closed -$16K 459
2014
Q3
$16K Buy
+48
New +$16K ﹤0.01% 449